| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/28/2000 | WO2000056749A1 N-acylphosphoramidites and their use in oligonucleotide synthesis |
| 09/28/2000 | WO2000056748A1 Xylo-lna analogues |
| 09/28/2000 | WO2000056747A1 2'-substituted rna preparation |
| 09/28/2000 | WO2000056740A1 Boronic acid containing reagents and oligonucleotides |
| 09/28/2000 | WO2000056342A2 Use of stabilised oligonucleotides for preparing a medicine with antitumour activity |
| 09/28/2000 | CA2371990A1 Use of stabilised oligonucleotides for preparing a medicine with antitumour activity |
| 09/28/2000 | CA2370478A1 N-acylphosphoramidites and their use in oligonucleotide synthesis |
| 09/28/2000 | CA2368101A1 Boronic acid containing reagents and oligonucleotides |
| 09/28/2000 | CA2362714A1 2'-substituted rna preparation |
| 09/27/2000 | WO2001016367A1 Methods for exogenous, internal controls during nucleic acid amplification |
| 09/27/2000 | EP1038963A2 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods |
| 09/27/2000 | EP1038955A1 Method for extraction and long-term storage of RNA |
| 09/27/2000 | EP1038530A2 Immunomodulator comprising DNA |
| 09/27/2000 | EP1037979A2 Polypeptides and nucleic acids encoding the same |
| 09/27/2000 | EP1037973A2 Method for isolating short and long-chain nucleic acids |
| 09/27/2000 | EP1037971A1 Methods of nucleic acid isolation |
| 09/27/2000 | EP1037969A1 Fibrinogen-converting enzyme hybrids |
| 09/27/2000 | EP1037965A1 Methods for preparation of vaccines against cancer |
| 09/27/2000 | EP1037660A1 ribB |
| 09/27/2000 | EP1037654A1 ribA |
| 09/27/2000 | EP0689592B1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 09/27/2000 | CN1267730A New human potassium ion passage regulating factor protein and its code sequence |
| 09/27/2000 | CN1267729A New human macroglycoprotein relating protein and its code sequence |
| 09/27/2000 | CN1267728A New human sexual differentiation determining factor protein and its code sequence |
| 09/27/2000 | CN1267727A New human phosphorylated zymoprotein of pyruvate dehydrogenase and its code sequence |
| 09/27/2000 | CN1267519A Immune regulator, immune regulator food and immune regulator fodder |
| 09/27/2000 | CN1056747C Diagnosis and treatment of virus infections associated with chronic fatigue |
| 09/26/2000 | US6124450 Processes and intermediates for phosphorous-containing covalent linkages |
| 09/26/2000 | US6124449 High affinity TGFβ nucleic acid ligands and inhibitors |
| 09/26/2000 | US6124445 Phosphotriester oligonucleotides, amidities and method of preparation |
| 09/26/2000 | US6124429 Fibrous protein to be used as biocompatible polymer for surgical sutures, artificial blood vessels and artificial tissues |
| 09/26/2000 | US6124128 Nucleic acid coding green fluorescent protein; for use as marker of gene expression, tracers of cell lineage and as fusion tags to monitor protein localization within viable cells |
| 09/26/2000 | US6124113 Fermentative carotenoid production |
| 09/26/2000 | US6124102 Methods for determining receptor-ligand binding using probe arrays |
| 09/26/2000 | US6124099 Method for placing a photo-cross-linking agent at specific internal sites within the sequence of synthetic strands of ribonucleic acids |
| 09/26/2000 | US6124090 Nucleic acid amplification using single primer |
| 09/26/2000 | CA2283470A1 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 09/26/2000 | CA2103460C Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 09/21/2000 | WO2000055371A1 27 human secreted proteins |
| 09/21/2000 | WO2000055179A1 Novel phosphate and thiophosphate protecting groups |
| 09/21/2000 | WO2000055170A1 Methods for removing dimethoxytrityl groups from oligonucleotides |
| 09/21/2000 | CA2368068A1 27 human secreted proteins |
| 09/20/2000 | EP1036845A2 Downstream genes of tumor suppressor WT1 |
| 09/20/2000 | EP1036186A1 Ribozymes capable of conferring resistance to potyvirus infection, and plants expressing said ribozymes |
| 09/20/2000 | EP1036094A1 Cyp7 promoter-binding factors |
| 09/20/2000 | EP1036085A1 Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics |
| 09/20/2000 | EP1036082A2 Isolation of nucleic acids |
| 09/20/2000 | EP1035870A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 09/20/2000 | EP1035861A1 Threonine-containing protegrins |
| 09/20/2000 | EP0742834B1 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell |
| 09/20/2000 | CN1267224A Treatment of acute lung injury and fibrosis with antagonists of 'alpha' V 'beta' b |
| 09/20/2000 | CN1267223A Carcinostatic agents |
| 09/20/2000 | CN1266899A Precursor heteromorphic protein of human calcium binding protein and its coding sequence |
| 09/20/2000 | CN1266898A Human carboxypeptidase precursor protein and its coding sequence |
| 09/20/2000 | CN1056617C Melanoma-inhibiting protein |
| 09/19/2000 | US6121437 Phosphate and thiophosphate protecting groups |
| 09/19/2000 | US6121434 An oligonucleotide diagnostic agent; for the diagnosis and treatment of cancer, restenosis, a nd viral diseases affected by intergrins |
| 09/19/2000 | US6121433 For diagnostic, research and therapeutic use; mimic or modulate proteins, enzymes, nucleic acids and lipids |
| 09/19/2000 | US6121014 Method for producing a plant-optimized nucleic acid coding sequence |
| 09/19/2000 | US6120996 Accurate and reproducible proecess by cleaving cdna corresponding to messenger rna with restriction endonuclease, amplifying with one or more primers, separating fragments and assessing amounts of fragments |
| 09/19/2000 | US6120987 Simple and rapid process by contacting target and fluorophore of cyanin, merocyanin, hemicyanin, or styryl dye with aqueous solution of water-soluble macrocycle |
| 09/19/2000 | US6120985 Pressure-enhanced extraction and purification |
| 09/19/2000 | US6120765 Purified peptide |
| 09/19/2000 | CA2273834A1 Immunomodulator, immunomodulator food and immunomodulator feed |
| 09/14/2000 | WO2000053812A2 Replica amplification of nucleic acid arrays |
| 09/14/2000 | WO2000053807A1 Solid medium and process for the storage and rapid purification of nucleic acid |
| 09/14/2000 | WO2000053785A2 Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins |
| 09/14/2000 | WO2000053749A2 Vascular adhesion molecules and modulation of their function |
| 09/14/2000 | WO2000053623A1 Bifunctional molecules for delivery of therapeutics |
| 09/14/2000 | WO2000053617A1 Methods and compositions for economically synthesizing and assembling long dna sequences |
| 09/14/2000 | WO2000053616A2 Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage |
| 09/14/2000 | WO2000053309A1 Method for photolytically deprotecting immobilized nucleoside derivatives, especially in the production of dna chips |
| 09/14/2000 | WO2000030425A3 Method of using pon-1 to decrease atheroma formation |
| 09/14/2000 | WO2000013018A3 Support for a method for determining analytes and a method for producing the support |
| 09/14/2000 | CA2582809A1 Replica amplification of nucleic acid arrays |
| 09/14/2000 | CA2411514A1 Nucleotide compounds having a cleavable linker |
| 09/14/2000 | CA2366689A1 Bifunctional molecules for delivery of therapeutics |
| 09/14/2000 | CA2365226A1 Immobilising polynucleotides |
| 09/14/2000 | CA2362699A1 Method for photolytically deprotecting immobilized nucleoside derivatives, especially in the production of dna chips |
| 09/13/2000 | EP1035214A2 A 3'-end modified nucleic acid probe, suitable for hybridization and detection via fluorescence |
| 09/13/2000 | EP1034785A2 Hepatitis C virus diagnostics and vaccines |
| 09/13/2000 | EP1034301A1 Inhibition of an fgf-binding protein using ribozymes |
| 09/13/2000 | EP1034221A1 Dibenzorhodamine dyes useful as fluorescent labelling agents |
| 09/13/2000 | EP1034180A2 Linker nucleoside, and production and use of the same |
| 09/13/2000 | EP1033996A1 Prevention and treatment of amyloidogenic disease |
| 09/13/2000 | EP1033992A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 09/13/2000 | EP0853680A4 Method for precipitating nucleic acid with visible carrier |
| 09/13/2000 | EP0826066B1 Methods and reagents for combined pcr amplification and hybridization probing assay |
| 09/13/2000 | EP0733059B1 Compounds and methods for site-directed mutations in eukaryotic cells |
| 09/13/2000 | EP0586570B1 Backbone modified oligonucleotide analogues |
| 09/13/2000 | EP0514488B1 Retinoid receptor compositions and methods |
| 09/13/2000 | CN1056382C Improved HCV diagnostic agents |
| 09/13/2000 | CN1056380C Antisense nucleoside for inhibiting growth of human malignant tumor |
| 09/13/2000 | CN1056379C Method for preparing nucleic acid organic feed from leftover bits of farm and sideline products |
| 09/12/2000 | US6117993 Synthons for oligonucleotide synthesis |
| 09/12/2000 | US6117992 Nucleoside synthon having stable sulfur protecting group which prevents oxidation and thus phosphormonothioate production |
| 09/12/2000 | US6117991 Plasmid pav2-htsh-beta on deposit as atcc 75505; for recombinant production, diagnosis and therapy of human thyroid cancer; anticarcinogenic agents |
| 09/12/2000 | US6117988 Contains a neutral, stereoregular linking group based on replacement of the phosphoryl with a sulfonyl group; nuclease resistance |
| 09/12/2000 | US6117986 Pyrimidines linked to a quencher |
| 09/12/2000 | US6117973 Peptide nucleic acid monomers; for use as probes to detect nucleic acids |